| Pharmaceutical Information |
| Drug Name |
Almotriptan malate |
| Drug ID |
BADD_D00078 |
| Description |
Almotriptan is a triptan drug for the treatment of migraine headaches. Almotriptan is in a class of medications called selective serotonin receptor agonists. It works by narrowing blood vessels in the brain, stopping pain signals from being sent to the brain, and stopping the release of certain natural substances that cause pain, nausea, and other symptoms of migraine. Almotriptan does not prevent migraine attacks. |
| Indications and Usage |
For the treatment of acute migraine headache in adults |
| Marketing Status |
approved; investigational |
| ATC Code |
N02CC05 |
| DrugBank ID |
DB00918
|
| KEGG ID |
D02825
|
| MeSH ID |
C409045
|
| PubChem ID |
123607
|
| TTD Drug ID |
D0P0SM
|
| NDC Product Code |
14501-0073; 0093-5260; 0093-5261; 65015-673; 67835-5003 |
| UNII |
PJP312605E
|
| Synonyms |
almotriptan | almotriptan malate | Axert | Almogran |
|
| Chemical Information |
| Molecular Formula |
C21H31N3O7S |
| CAS Registry Number |
181183-52-8 |
| SMILES |
CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3.C(C(C(=O)O)O)C(=O)O |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
